Insider Trading disclosures for Curis Inc

The latest disclosure was made by James E. Dentzer in Curis Inc where a trade of 40,000 Employee stock option (right to buy) done was reported to US exchanges on Jan. 28, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Show

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
James E. Dentzer	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Jan 2025	40,000	40,000	-		-	Employee stock option (right to buy)
Kenneth I. Kaitin	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Jan 2025	1,600	1,600	-		-	Non Qualified Stock Option
Marc Rubin	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Jan 2025	1,600	1,600	-		-	Non Qualified Stock Option
Martyn D. Greenacre	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Jan 2025	1,600	1,600	-		-	Non Qualified Stock Option
John A. Hohneker	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Jan 2025	1,600	1,600	-		-	Non Qualified Stock Option
Diantha Duvall	CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Jan 2025	15,000	15,000	-		-	Employee stock option (right to buy)
Jonathan B. Zung	CDO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Jan 2025	15,000	15,000	-		-	Employee stock option (right to buy)
James E. Dentzer	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 May 2024	100,000	100,000	-		-	Employee stock option (right to buy)
Kenneth I. Kaitin	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 May 2024	4,250	4,250	-		-	Non Qualified Stock Option
Marc Rubin	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 May 2024	4,250	4,250	-		-	Non Qualified Stock Option
Martyn D. Greenacre	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 May 2024	4,250	4,250	-		-	Non Qualified Stock Option
John A. Hohneker	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 May 2024	4,250	4,250	-		-	Non Qualified Stock Option
Diantha Duvall	CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 May 2024	39,000	39,000	-		-	Employee stock option (right to buy)
Jonathan B. Zung	CDO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 May 2024	40,700	40,700	-		-	Employee stock option (right to buy)
Kenneth I. Kaitin	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2023	85,000	85,000	-		-	Non Qualified Stock Option
Marc Rubin	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2023	85,000	85,000	-		-	Non Qualified Stock Option
Martyn D. Greenacre	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2023	85,000	85,000	-		-	Non Qualified Stock Option
John A. Hohneker	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2023	85,000	85,000	-		-	Non Qualified Stock Option
James E. Dentzer	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jan 2023	1,000,000	1,000,000	-		-	Employee stock option (right to buy)
Robert E. Martell	Head of Research & Development	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jan 2023	350,000	350,000	-		-	Employee stock option (right to buy)
Diantha Duvall	CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jan 2023	500,000	500,000	-		-	Employee stock option (right to buy)
Kenneth I. Kaitin	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2022	85,000	85,000	-		-	Non Qualified Stock Option
Marc Rubin	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2022	85,000	85,000	-		-	Non Qualified Stock Option
Martyn D. Greenacre	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2022	85,000	85,000	-		-	Non Qualified Stock Option
Lori Anne Kunkel	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2022	85,000	85,000	-		-	Non Qualified Stock Option
John A. Hohneker	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2022	85,000	85,000	-		-	Non Qualified Stock Option
Robert E. Martell	Head of Research & Development	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2022	252,000	252,000	-		-	Employee stock option (right to buy)
William E. Steinkrauss	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jan 2022	360,000	360,000	-		-	Employee stock option (right to buy)
James E. Dentzer	Director, President & CEO	Sale of securities on an exchange or to another person at price $ 3.07 per share.	27 Jan 2022	3,094	64,877 (0%)	0%	3.1	9,499	Common Stock
James E. Dentzer	Director, President & CEO	Sale of securities on an exchange or to another person at price $ 3.18 per share.	27 Jan 2022	2,406	67,971 (0%)	0%	3.2	7,651	Common Stock
James E. Dentzer	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Jan 2022	825,000	825,000	-		-	Employee stock option (right to buy)
James E. Dentzer	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Jan 2021	330,000	330,000	-		-	Employee stock option (right to buy)
Kenneth I. Kaitin	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Jan 2021	33,000	33,000	-		-	Non Qualified Stock Option
Marc Rubin	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Jan 2021	33,000	33,000	-		-	Non Qualified Stock Option
Martyn D. Greenacre	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Jan 2021	33,000	33,000	-		-	Non Qualified Stock Option
Robert Martell	Head of Research & Development	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Jan 2021	126,000	126,000	-		-	Employee stock option (right to buy)
Lori Anne Kunkel	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Jan 2021	33,000	33,000	-		-	Non Qualified Stock Option
William Steinkrauss	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Jan 2021	180,000	180,000	-		-	Employee stock option (right to buy)
James E. Dentzer	Director, President & CEO	Sale of securities on an exchange or to another person at price $ 10.96 per share.	25 Jan 2021	2,283	70,362 (0%)	0%	11.0	25,022	Common Stock
James E. Dentzer	Director, President & CEO	Sale of securities on an exchange or to another person at price $ 10.59 per share.	25 Jan 2021	3,094	67,268 (0%)	0%	10.6	32,758	Common Stock
James E. Dentzer	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Mar 2020	750,000	750,000	-		-	Employee stock option (right to buy)
Kenneth I. Kaitin	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Mar 2020	180,000	180,000	-		-	Non Qualified Stock Option
Marc Rubin	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Mar 2020	180,000	180,000	-		-	Non Qualified Stock Option
Martyn D. Greenacre	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Mar 2020	180,000	180,000	-		-	Non Qualified Stock Option
Robert Martell	Head of Research & Development	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Mar 2020	385,000	385,000	-		-	Employee stock option (right to buy)
Lori Anne Kunkel	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Mar 2020	180,000	180,000	-		-	Non Qualified Stock Option
William Steinkrauss	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Mar 2020	385,000	385,000	-		-	Employee stock option (right to buy)
Mark W. Noel	Vice-President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Feb 2020	22,632	22,632	-		-	Non-qualified stock option (right to buy)
Mark W. Noel	Vice-President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Feb 2020	37,368	37,368	-		-	Qualified stock option (right to buy)
James E. Dentzer	Director, President & CEO	Sale of securities on an exchange or to another person at price $ 1.69 per share.	23 Jan 2020	3,658	45,252 (0%)	0%	1.7	6,182	Common Stock

Showing 1 to 50 of 500 entries

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

New 52W Low today

High volume today

Insider Trading disclosures for Curis Inc

The latest disclosure was made by James E. Dentzer in Curis Inc where a trade of 40,000 Employee stock option (right to buy) done was reported to US exchanges on Jan. 28, 2025.

Screeners based on Insider Trading and SAST parameters